Davenport & Co’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-27,170
| Closed | -$101K | – | 1008 |
|
|
2022
Q2 | $101K | Sell |
27,170
-500
| -2% | -$1.86K | ﹤0.01% | 941 |
|
|
2022
Q1 | $180K | Hold |
27,670
| – | – | ﹤0.01% | 982 |
|
|
2021
Q4 | $322K | Sell |
27,670
-55,100
| -67% | -$641K | ﹤0.01% | 864 |
|
|
2021
Q3 | $1.54M | Buy |
82,770
+69,020
| +502% | +$1.29M | 0.01% | 443 |
|
|
2021
Q2 | $292K | Sell |
13,750
-6,400
| -32% | -$136K | ﹤0.01% | 802 |
|
|
2021
Q1 | $409K | Buy |
+20,150
| New | +$409K | ﹤0.01% | 576 |
|